GALECTIN THERAPEUTICS INC (GALT) Common Stock, Shares, Outstanding 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Galectin Therapeutics Inc quarterly Common Stock, Shares, Outstanding history and growth rate from 2010 to 2024.
  • Galectin Therapeutics Inc Common Stock, Shares, Outstanding for the quarter ending March 31, 2024 was 62.1 M shares, a 4.31% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 62.1 M +2.57 M +4.31% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 61.9 M +2.43 M +4.08% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 61.8 M +2.42 M +4.08% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 59.6 M +186 K +0.31% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 59.6 M +194 K +0.33% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 59.4 M +84.7 K +0.14% Dec 31, 2022 10-K 2024-03-29
Q3 2022 59.4 M +84.7 K +0.14% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 59.4 M +121 K +0.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 59.4 M +2.2 M +3.85% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 59.3 M +2.26 M +3.97% Dec 31, 2021 10-K 2023-03-30
Q3 2021 59.3 M +2.26 M +3.97% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 59.3 M +2.38 M +4.18% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 57.2 M +292 K +0.51% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 57.1 M +182 K +0.32% Dec 31, 2020 10-K 2022-03-31
Q3 2020 57.1 M +418 K +0.74% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 56.9 M +303 K +0.54% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 56.9 M +11.3 M +24.8% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 56.9 M +15.7 M +38.1% Dec 31, 2019 10-K 2021-03-31
Q3 2019 56.7 M +15.5 M +37.7% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 56.6 M +16 M +39.3% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 45.6 M +7.95 M +21.1% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 41.2 M +5.4 M +15.1% Dec 31, 2018 10-K 2020-03-16
Q3 2018 41.1 M +5.5 M +15.4% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 40.6 M +5.66 M +16.2% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 37.6 M +2.98 M +8.58% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 35.8 M +2.88 M +8.74% Dec 31, 2017 10-K 2019-03-06
Q3 2017 35.6 M +6.24 M +21.2% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 35 M +5.69 M +19.4% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 34.7 M +5.69 M +19.6% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 32.9 M +4.09 M +14.2% Dec 31, 2016 10-K 2018-03-29
Q3 2016 29.4 M +5.47 M +22.8% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 29.3 M +5.49 M +23.1% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 29 M +5.25 M +22.1% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 28.8 M +6.55 M +29.4% Dec 31, 2015 10-K 2017-03-28
Q3 2015 23.9 M +1.81 M +8.16% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 23.8 M +1.75 M +7.96% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 23.7 M +1.82 M +8.33% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 22.3 M +3.89 M +21.2% Dec 31, 2014 10-K 2016-03-15
Q3 2014 22.1 M +4.47 M +25.3% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 22 M +5.74 M +35.2% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 21.9 M +5.72 M +35.3% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 18.4 M +2.33 M +14.5% Dec 31, 2013 10-K 2015-03-18
Q3 2013 17.7 M +1.68 M +10.6% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 16.3 M +480 K +3.04% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 16.2 M +520 K +3.32% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 16.1 M +3.14 M +24.3% Dec 31, 2012 10-K 2014-03-21
Q3 2012 16 M -60.9 M -79.2% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 15.8 M -58.2 M -78.6% Jun 30, 2012 10-Q 2012-08-10
Q1 2012 15.7 M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 12.9 M +2.27 M +21.3% Dec 31, 2011 10-K 2013-03-29
Q3 2011 76.9 M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 74.1 M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 10.7 M Dec 31, 2010 10-K 2012-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.